You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pancreatic ca

Showing 1 - 25 of 5,219
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma Trial (mFOLFIRINOX plus radiotherapy)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • mFOLFIRINOX plus radiotherapy
  • (no location specified)
Nov 21, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial

Not yet recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Biopsy
  • +8 more
  • (no location specified)
Jan 13, 2023

Candidates for Neoadjuvant Treatment in Resectable Pancreatic

Completed
  • Pancreatic Cancer
  • Neoadjuvant
  • Neoadjuvant treatment
  • (no location specified)
Nov 9, 2023

Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of

Completed
  • Pancreas Cancer
    • (no location specified)
    Jul 15, 2023

    Pancreatic Cancer Using CA19-9 and Fecal Elastase

    Active, not recruiting
    • Paancreatic Cancer
      • Seoul, Korea, Republic of
        Gangnam Severance Hospital
      Jun 27, 2023

      Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

      Completed
      • Chronic Myeloid Leukemia (CML)
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 31, 2022

      Colon Cancer, Pancreatic Cancer, Cholangiocarcinoma Trial run by the National Cancer Institute (NCI) (MVT-5873, pancreatectomy

      Completed
      • Colon Cancer
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jun 30, 2022

      Metastatic Pancreatic Cancer Trial in Rotterdam (MesoPher, Mitazalimab)

      Recruiting
      • Metastatic Pancreatic Cancer
      • MesoPher
      • Mitazalimab
      • Rotterdam, Zuid-Holland, Netherlands
        Erasmus MC
      Dec 6, 2022

      Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

      Not yet recruiting
      • Metastatic Pancreatic Cancer
      • Durvalumab
      • Rintatolimod
      • Rotterdam, Zuid-Holland, Netherlands
        Erasmus MC
      Jun 23, 2023

      PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With

      Recruiting
      • Pancreatic Cancer
      • +4 more
      • PET Scan
      • +3 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Feb 10, 2023

      Panc CA Risk Model & Biomarker Testing In High-Risk Cohort

      Not yet recruiting
      • Pancreatic Adenocarcinoma
      • Blood Specimen
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Sep 5, 2022

      Pancreatic Cancer Trial in United States (MVT-5873, modified FOLFIRINOX (mFOLFIRINOX))

      Recruiting
      • Pancreatic Cancer
      • Scottsdale, Arizona
      • +3 more
      Aug 17, 2022

      A Combination of AKR1B10 and CA19-9 Improves Diagnosis of PDAC

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
        • Shanghai, Shanghai, China
        • +2 more
        Jul 13, 2022

        "Effect of Screening Using Imaging on Early Detection of PDAC in

        Not yet recruiting
        • Pancreatic Ductal Adenocarcinoma (PDAC)
        • A blood sample for CA 19-9 (cancer detection test)
        • (no location specified)
        Sep 13, 2023

        Pancreatic Carcinoma, Tumors That Express CA 19-9 Trial in Scottsdale, New York (MVT-1075, MVT-5873)

        Suspended
        • Pancreatic Carcinoma
        • Tumors That Express CA 19-9
        • Scottsdale, Arizona
        • +1 more
        Aug 23, 2022

        Pancreatic Cancer, Tumors That Express CA19-9 Trial in United States (MVT-2163, MVT-5873)

        Recruiting
        • Pancreatic Cancer
        • Tumors That Express CA19-9
        • Basking Ridge, New Jersey
        • +6 more
        May 3, 2022

        Life Changes Experienced by Patients With Pancreatic Cancer

        Active, not recruiting
        • Pancreatic Cancer
        • Measurement of Transitions in Cancer Scale (MOT-CA) Survey
        • Distress Thermometer Survey
        • New York, New York
          Memorial Sloan Kettering Cancer Center (All Protocol Activities)
        Feb 2, 2022

        Metastatic Pancreatic Cancer Trial in Scottsdale (diagnostic test, other, drug)

        Completed
        • Metastatic Pancreatic Cancer
        • Safety Laboratories
        • +7 more
        • Scottsdale, Arizona
          HonorHealth Research Institute
        Jul 14, 2021

        Longitudinal Pancreatic Cancer Study

        Completed
        • Pancreatic Cancer
        • CA 19-9 Assay
        • Boca Raton, Florida
        • +6 more
        Aug 16, 2021

        Pancreatic Adenocarcinoma Trial (Nab paclitaxel, Gemcitabine, mFOLFIRINOX)

        Not yet recruiting
        • Pancreatic Adenocarcinoma
        • Nab paclitaxel
        • +2 more
        • (no location specified)
        Apr 6, 2021

        Pancreatic Carcinoma, Tumors That Express CA19-9 Trial in New York (MVT-2163, MVT-5873)

        Terminated
        • Pancreatic Carcinoma
        • Tumors That Express CA19-9
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Aug 26, 2021

        Pancreatic Cancer Trial in New Orleans, Dallas (XB2001 or Placebo)

        Recruiting
        • Pancreatic Cancer
        • XB2001 or Placebo
        • Tucson, Arizona
        • +27 more
        Jan 27, 2023

        Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation Trial in United States (drug, diagnostic test, other)

        Recruiting
        • Pancreas Cancer
        • +4 more
        • New Haven, Connecticut
        • +7 more
        Dec 12, 2022

        Islet Transplantation in Diabetes Type 1 Trial in Worldwide (Reparixin, Placebo)

        Completed
        Has Results
        • Islet Transplantation in Diabetes Mellitus Type 1
        • Chicago, Illinois
        • +8 more
        Sep 23, 2021

        Malignant Solid Tumors, Lymphoma, Ovarian Cancer Trial in Canada, United States (AZD5153, Olaparib)

        Completed
        • Malignant Solid Tumors
        • +5 more
        • Sarasota, Florida
        • +3 more
        May 5, 2021